Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study

Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2421-2425. doi: 10.1007/s10096-021-04261-y. Epub 2021 Apr 23.

Abstract

We performed a prospective cohort study of 311 outpatients with non-severe COVID-19 (187 women, median age 39 years). Of the 214 (68.8%) who completed the 6-week follow-up questionnaire, 115 (53.7%) had recovered. Others mostly reported dyspnea (n = 86, 40.2%), weight loss (n = 83, 38.8%), sleep disorders (n = 68, 31.8%), and anxiety (n = 56, 26.2%). Of those who developed ageusia and anosmia, these symptoms were still present at week 6 in, respectively, 11/111 (9.9%) and 19/114 (16.7%). Chest CT scan and lung function tests found no explanation in the most disabled patients (n = 23). This study confirms the high prevalence of persistent symptoms after non-severe COVID-19.

Keywords: Asthenia; COVID-19; Dyspnea; Investigations; Persistent symptoms; Prospective cohort.

MeSH terms

  • Adult
  • Ageusia / epidemiology*
  • Anosmia / epidemiology*
  • Anxiety / epidemiology*
  • COVID-19 / diagnostic imaging
  • COVID-19 / epidemiology*
  • Dyspnea / epidemiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Prospective Studies
  • SARS-CoV-2